10-103076754-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_017649.5(CNNM2):​c.2419-217A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 152,226 control chromosomes in the GnomAD database, including 1,532 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.12 ( 1532 hom., cov: 32)

Consequence

CNNM2
NM_017649.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.357

Publications

14 publications found
Variant links:
Genes affected
CNNM2 (HGNC:103): (cyclin and CBS domain divalent metal cation transport mediator 2) This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play an important role in magnesium homeostasis by mediating the epithelial transport and renal reabsorption of Mg2+. Mutations in this gene are associated with renal hypomagnesemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
CNNM2 Gene-Disease associations (from GenCC):
  • hypomagnesemia, seizures, and intellectual disability 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
  • renal hypomagnesemia 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 10-103076754-A-G is Benign according to our data. Variant chr10-103076754-A-G is described in ClinVar as Benign. ClinVar VariationId is 1243956.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNNM2NM_017649.5 linkc.2419-217A>G intron_variant Intron 7 of 7 ENST00000369878.9 NP_060119.3
CNNM2NM_199076.3 linkc.2353-217A>G intron_variant Intron 6 of 6 NP_951058.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNNM2ENST00000369878.9 linkc.2419-217A>G intron_variant Intron 7 of 7 1 NM_017649.5 ENSP00000358894.3
CNNM2ENST00000433628.2 linkc.2353-217A>G intron_variant Intron 6 of 6 2 ENSP00000392875.2
CNNM2ENST00000475511.1 linkn.473-217A>G intron_variant Intron 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.124
AC:
18787
AN:
152108
Hom.:
1533
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0322
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.119
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.0843
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.185
Gnomad OTH
AF:
0.0990
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.123
AC:
18778
AN:
152226
Hom.:
1532
Cov.:
32
AF XY:
0.122
AC XY:
9085
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0321
AC:
1335
AN:
41552
American (AMR)
AF:
0.105
AC:
1609
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
412
AN:
3472
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5186
South Asian (SAS)
AF:
0.0842
AC:
406
AN:
4822
European-Finnish (FIN)
AF:
0.199
AC:
2113
AN:
10596
Middle Eastern (MID)
AF:
0.0714
AC:
21
AN:
294
European-Non Finnish (NFE)
AF:
0.185
AC:
12556
AN:
67988
Other (OTH)
AF:
0.0980
AC:
207
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
838
1676
2515
3353
4191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.159
Hom.:
3990
Bravo
AF:
0.111
Asia WGS
AF:
0.0390
AC:
139
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
10
DANN
Benign
0.58
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296569; hg19: chr10-104836511; API